-
1
-
-
0026689387
-
Cyclosporine in rheumatoid arthritis: Documented efficacy and safety
-
Tugwell P: Cyclosporine in rheumatoid arthritis: Documented efficacy and safety. Semin Arthritis Rheum 1992;(suppl 3)21:30-8.
-
(1992)
Semin Arthritis Rheum
, vol.21
, Issue.3 SUPPL.
, pp. 30-38
-
-
Tugwell, P.1
-
3
-
-
0029093391
-
Cyclosporine in rheumatoid arthritis: An overview
-
Førre Ø: Cyclosporine in rheumatoid arthritis: An overview. Clin Rheumatol 1995;(suppl 2)14:33-6.
-
(1995)
Clin Rheumatol
, vol.14
, Issue.2 SUPPL.
, pp. 33-36
-
-
Førre, Ø.1
-
5
-
-
0023105608
-
Enhancement of cyclosporin A nephrotoxicity by diclofenac
-
Deray G, Le Hoang P, Aupetit B, et al: Enhancement of cyclosporin A nephrotoxicity by diclofenac (letter). Clin Nephrol 1987;27:213-4.
-
(1987)
Clin Nephrol
, vol.27
, pp. 213-214
-
-
Deray, G.1
Le Hoang, P.2
Aupetit, B.3
-
6
-
-
0023708322
-
Nonsteroidal antiinflammatory drugs and cyclosporin: A potentially serious adverse interaction
-
Harris KP, Jenkins D, Walls J: Nonsteroidal antiinflammatory drugs and cyclosporin: A potentially serious adverse interaction (letter). Transplantation 1988;46:598-9.
-
(1988)
Transplantation
, vol.46
, pp. 598-599
-
-
Harris, K.P.1
Jenkins, D.2
Walls, J.3
-
7
-
-
0025970746
-
Cyclosporin and diclofenac interaction in rheumatoid arthritis
-
Branthwaite JP, Nicholls A: Cyclosporin and diclofenac interaction in rheumatoid arthritis (letter). Lancet 1991;337:252.
-
(1991)
Lancet
, vol.337
, pp. 252
-
-
Branthwaite, J.P.1
Nicholls, A.2
-
8
-
-
0024410995
-
Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis
-
Berg KJ, Førre Ø, Djoseland M, et al: Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis. Clin Nephrol 1989;31:232-8.
-
(1989)
Clin Nephrol
, vol.31
, pp. 232-238
-
-
Berg, K.J.1
Førre, Ø.2
Djoseland, M.3
-
9
-
-
0026673504
-
Interaction of cyclosporin A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis
-
Altman RD, Perez GO, Sfakianakis GN: Interaction of cyclosporin A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am J Med 1992;93:396-402.
-
(1992)
Am J Med
, vol.93
, pp. 396-402
-
-
Altman, R.D.1
Perez, G.O.2
Sfakianakis, G.N.3
-
10
-
-
0027360295
-
Pharmacokinetics of cyclosporine and multiple-dose diclofenac during coadministration
-
Mueller EA, Kovarik JM, Koelle EU, et al: Pharmacokinetics of cyclosporine and multiple-dose diclofenac during coadministration. J Clin Pharmacol 1993;33:936-43.
-
(1993)
J Clin Pharmacol
, vol.33
, pp. 936-943
-
-
Mueller, E.A.1
Kovarik, J.M.2
Koelle, E.U.3
-
11
-
-
0023945481
-
American rheumatism association 1987 revised criteria for the classification of RA
-
Arnett FC, Edworthy SM, Bloch DA, et al: American rheumatism association 1987 revised criteria for the classification of RA. Arthritis Rheum 1988;31:315-24.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
-
12
-
-
0023818445
-
3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood
-
3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood. Clin Chem 1988;34:257-60.
-
(1988)
Clin Chem
, vol.34
, pp. 257-260
-
-
Ball, P.E.1
Munzer, H.2
Keller, H.P.3
-
13
-
-
0025861932
-
The relative bioavailability of diclofenac with respect to time of administration
-
Mustofa M, Suryawati S, Dwiprahasto I, Santoso B: The relative bioavailability of diclofenac with respect to time of administration. Br J Clin Pharmacol 1991;32:246-7.
-
(1991)
Br J Clin Pharmacol
, vol.32
, pp. 246-247
-
-
Mustofa, M.1
Suryawati, S.2
Dwiprahasto, I.3
Santoso, B.4
-
14
-
-
0023976547
-
Diclofenac sodium: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
-
Todd PA, Sorkin EM: Diclofenac sodium: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988;35:244-85.
-
(1988)
Drugs
, vol.35
, pp. 244-285
-
-
Todd, P.A.1
Sorkin, E.M.2
-
15
-
-
0027193864
-
Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration
-
Kovarik JM, Mueller EA, Gaber M, et al: Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration. J Clin Pharmacol 1993;13:513-21.
-
(1993)
J Clin Pharmacol
, vol.13
, pp. 513-521
-
-
Kovarik, J.M.1
Mueller, E.A.2
Gaber, M.3
-
16
-
-
0344634038
-
NSAIDs from various chemical classes competitively inhibit P450TB (CYP2C)
-
Leeman TD, Kondo M, Dayer P: NSAIDs from various chemical classes competitively inhibit P450TB (CYP2C) (abstr). Clin Pharmacol Ther 1992;51:179.
-
(1992)
Clin Pharmacol Ther
, vol.51
, pp. 179
-
-
Leeman, T.D.1
Kondo, M.2
Dayer, P.3
-
17
-
-
0024208892
-
Cyclosporin A in severe, treatment-refractory rheumatoid arthritis
-
Yocum DE, Klippel JH, Wilder RL, et al: Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. Ann Intern Med 1988;109:863-9.
-
(1988)
Ann Intern Med
, vol.109
, pp. 863-869
-
-
Yocum, D.E.1
Klippel, J.H.2
Wilder, R.L.3
-
18
-
-
0023897330
-
Serum creatinine levels two years later: Follow-up of a placebo-controlled trial of cyclosporine in rheumatoid arthritis patients
-
Boers M, van Rijthoven AWAM, Goei The HS, et al: Serum creatinine levels two years later: Follow-up of a placebo-controlled trial of cyclosporine in rheumatoid arthritis patients. Transplant Proc 1988;(suppl 4)3:371-5.
-
(1988)
Transplant Proc
, vol.3
, Issue.4 SUPPL.
, pp. 371-375
-
-
Boers, M.1
Van Rijthoven, A.W.A.M.2
Goei The, H.S.3
-
19
-
-
0026694617
-
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
-
Feutren G, Mihatsch MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992;326:1654-60.
-
(1992)
N Engl J Med
, vol.326
, pp. 1654-1660
-
-
Feutren, G.1
Mihatsch, M.J.2
-
20
-
-
0027960223
-
The use of cyclosporin A in rheumatoid arthritis. Conclusions of an international review
-
Panayi GS, Tugwell P: The use of cyclosporin A in rheumatoid arthritis. Conclusions of an international review. Br J Rheumatol 1994;33:967-9.
-
(1994)
Br J Rheumatol
, vol.33
, pp. 967-969
-
-
Panayi, G.S.1
Tugwell, P.2
|